Detalhe da pesquisa
1.
Discovery and SAR of 2-arylbenzotriazoles and 2-arylindazoles as potential treatments for Duchenne muscular dystrophy.
Bioorg Med Chem Lett
; 21(16): 4828-31, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21741236
2.
Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.
ACS Med Chem Lett
; 11(12): 2421-2427, 2020 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335663
3.
2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy.
J Med Chem
; 63(14): 7880-7891, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32551645
4.
Amino acid derived macrocycles--an area driven by synthesis or application?
Angew Chem Int Ed Engl
; 45(9): 1364-77, 2006 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16444788
5.
Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
J Med Chem
; 54(9): 3241-50, 2011 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21456623
6.
Synthesis and evaluation of a new biselector s-triazine based chiral stationary phase for enantioselective HPLC: potentiality of the approach and perspectives.
Biomed Chromatogr
; 19(6): 439-46, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16037927